Research graph
References from Intralesional Epidermal Growth Factor and Its Association with Reamputation and Level-Up Amputation in Diabetic Foot Patients with Post-Amputation Flap Necrosis: Clinical Outcomes and Macrophage Dynamics. Local targets link to admitted publications; unresolved targets remain external evidence.
Guidelines on multidisciplinary approaches for the prevention and management of diabetic foot disease (2020 edition)
10.1093/burnst/tkaa017 · 2020 · External reference
10.3389/fendo.2023.1323315
10.3389/fendo.2023.1323315 · External reference
Etiology, epidemiology, and disparities in the burden of diabetic foot ulcers
10.2337/dci22-0043 · 2023 · External reference
The global burden of diabetic foot disease
10.1016/s0140-6736(05)67698-2 · 2005 · External reference
Guidelines on interventions to enhance healing of foot ulcers in people with diabetes (IWGDF 2023 update)
10.1002/dmrr.3644 · 2024 · External reference
Primary necrotizing fasciitis of the breast: Case series with 5 patients
10.3855/jidc.14914 · 2022 · External reference
Time is of the essence when treating necrotizing soft tissue infections: A systematic review and meta-analysis
10.1186/s13017-019-0286-6 · 2020 · External reference
Can aggressive treatment of diabetic foot infections reduce the need for above-ankle amputation?
10.1093/clinids/23.2.286 · 1996 · External reference
Surgical management of the acute severely infected diabetic foot—The “infected diabetic foot attack”: An instructional review
10.1016/j.jcot.2021.04.012 · 2021 · External reference
Lisfranc and Chopart amputation: A systematic review
10.1097/md.0000000000033188 · 2023 · External reference
The effect of comorbid factors and amputation level on mortality in geriatric patients with diabetic foot
10.52312/jdrs.2023.818 · 2023 · External reference
Analysis of systemic risk factors between diabetic/vascular patients having primary lower limb amputations and re-amputations
10.1177/17085381231194964 · 2024 · External reference
Risk factors for failure after surgery in patients with diabetic foot syndrome
10.1177/24730114231182656 · 2023 · External reference
Diabetic foot ulcers and epidermal growth factor: Revisiting the local delivery route for a successful outcome
2017 · External reference
Intra-lesional injections of recombinant human epidermal growth factor promote granulation and healing in advanced diabetic foot ulcers: Multicenter, randomized, placebo-controlled, double-blind study
10.1111/j.1742-481x.2009.00641.x · 2009 · External reference
Autologous adipose-derived tissue stromal vascular fraction and intralesional epidermal growth factor combined application in patients with diabetic foot
10.12968/jowc.2024.0107 · 2025 · External reference
The use of autologous epidermal grafts for diabetic foot ulcer emergencies: A clinical study
2022 · External reference
The infected diabetic foot: Analysis of diabetic and non-diabetic foot infections
10.1111/wrr.13162 · 2024 · External reference
Diabetic Foot Ulcers: A Review
10.1001/jama.2023.10578 · 2023 · External reference
Five year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer
10.1186/s13047-020-00383-2 · 2020 · External reference
Prognostic factors in necrotizing soft-tissue infections: A cohort study
10.1016/j.jaad.2015.08.054 · 2015 · External reference
10.3389/fsurg.2021.655902
10.3389/fsurg.2021.655902 · External reference
Necrotizing fasciitis: Clinical presentation, microbiology, and determinants of mortality
10.2106/00004623-200308000-00005 · 2003 · External reference
Early diagnosis of necrotizing fasciitis
10.1002/bjs.9371 · 2014 · External reference
A comparison of necrotising fasciitis in diabetics and non-diabetics: A review of 127 patients
10.1302/0301-620x.98b11.37526 · 2016 · External reference
Surgery without postoperative antibiotic treatment in diabetic foot osteomyelitis is not associated with recurrence or limb loss
10.1016/j.diabres.2022.110177 · 2022 · External reference
Epidermal growth factor in healing diabetic foot ulcers: From gene expression to tissue healing and systemic biomarker circulation
10.37757/mr2020.v22.n3.7 · 2020 · External reference
Intralesional epidermal growth factor therapy in recalcitrant diabetic foot ulcers
10.12968/jowc.2023.32.sup4.s14 · 2023 · External reference
Intralesional injections of Citoprot-P in advanced diabetic foot ulcers with risk of amputation
10.1111/j.1742-481x.2007.00344.x · 2007 · External reference
Heberprot-P’s effect on gene expression in healing diabetic foot ulcers
10.37757/mr2018.v20.n3.4 · 2018 · External reference
Stimulation of wound healing by epidermal growth factor: A dose-dependent effect
10.1097/00000658-198604000-00007 · 1986 · External reference
Enhancement of wound healing by topical application of epidermal growth factor in an animal model
2020 · External reference
Negative-pressure wound therapy compared with advanced moist wound therapy: A comparative study on healing efficacy in diabetic foot ulcers
10.1016/j.surg.2024.109098 · 2025 · External reference
10.3390/biomedicines10123145
10.3390/biomedicines10123145 · External reference
Adjunctive hyperbaric oxygen therapy and negative pressure wound therapy for hard-to-heal wounds: A systematic review and meta-analysis
10.12968/jowc.2022.0213 · 2024 · External reference
Topical Recombinant Human Epidermal Growth Factor for Diabetic Foot Ulcers: A Meta-Analysis of Randomized Controlled Clinical Trials
10.1016/j.avsg.2019.05.041 · 2020 · External reference
Exosome-based cell therapy for diabetic foot ulcers: Present and prospect
10.1016/j.heliyon.2024.e39251 · 2024 · External reference
Limb salvage: A review of stem cell and growth factor therapies for diabetic foot ulcers
10.1016/j.diabres.2025.113036 · 2026 · External reference
Diabetic Foot Ulcers: A Review
10.1001/jama.2023.10578 · ExternalCitation · doi-reference
Early diagnosis of necrotizing fasciitis
10.1002/bjs.9371 · ExternalCitation · doi-reference
Guidelines on interventions to enhance healing of foot ulcers in people with diabetes (IWGDF 2023 update)
10.1002/dmrr.3644 · ExternalCitation · doi-reference
Topical Recombinant Human Epidermal Growth Factor for Diabetic Foot Ulcers: A Meta-Analysis of Randomized Controlled Clinical Trials
10.1016/j.avsg.2019.05.041 · ExternalCitation · doi-reference
Surgery without postoperative antibiotic treatment in diabetic foot osteomyelitis is not associated with recurrence or limb loss
10.1016/j.diabres.2022.110177 · ExternalCitation · doi-reference
Limb salvage: A review of stem cell and growth factor therapies for diabetic foot ulcers
10.1016/j.diabres.2025.113036 · ExternalCitation · doi-reference
Exosome-based cell therapy for diabetic foot ulcers: Present and prospect
10.1016/j.heliyon.2024.e39251 · ExternalCitation · doi-reference
Prognostic factors in necrotizing soft-tissue infections: A cohort study
10.1016/j.jaad.2015.08.054 · ExternalCitation · doi-reference
Surgical management of the acute severely infected diabetic foot—The “infected diabetic foot attack”: An instructional review
10.1016/j.jcot.2021.04.012 · ExternalCitation · doi-reference
Negative-pressure wound therapy compared with advanced moist wound therapy: A comparative study on healing efficacy in diabetic foot ulcers
10.1016/j.surg.2024.109098 · ExternalCitation · doi-reference
The global burden of diabetic foot disease
10.1016/s0140-6736(05)67698-2 · ExternalCitation · doi-reference
Guidelines on multidisciplinary approaches for the prevention and management of diabetic foot disease (2020 edition)
10.1093/burnst/tkaa017 · ExternalCitation · doi-reference
Can aggressive treatment of diabetic foot infections reduce the need for above-ankle amputation?
10.1093/clinids/23.2.286 · ExternalCitation · doi-reference
Stimulation of wound healing by epidermal growth factor: A dose-dependent effect
10.1097/00000658-198604000-00007 · ExternalCitation · doi-reference
Lisfranc and Chopart amputation: A systematic review
10.1097/md.0000000000033188 · ExternalCitation · doi-reference
Intralesional injections of Citoprot-P in advanced diabetic foot ulcers with risk of amputation
10.1111/j.1742-481x.2007.00344.x · ExternalCitation · doi-reference
Intra-lesional injections of recombinant human epidermal growth factor promote granulation and healing in advanced diabetic foot ulcers: Multicenter, randomized, placebo-controlled, double-blind study
10.1111/j.1742-481x.2009.00641.x · ExternalCitation · doi-reference
The infected diabetic foot: Analysis of diabetic and non-diabetic foot infections
10.1111/wrr.13162 · ExternalCitation · doi-reference
Analysis of systemic risk factors between diabetic/vascular patients having primary lower limb amputations and re-amputations
10.1177/17085381231194964 · ExternalCitation · doi-reference
Risk factors for failure after surgery in patients with diabetic foot syndrome
10.1177/24730114231182656 · ExternalCitation · doi-reference
Time is of the essence when treating necrotizing soft tissue infections: A systematic review and meta-analysis
10.1186/s13017-019-0286-6 · ExternalCitation · doi-reference
Five year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer
10.1186/s13047-020-00383-2 · ExternalCitation · doi-reference
Adjunctive hyperbaric oxygen therapy and negative pressure wound therapy for hard-to-heal wounds: A systematic review and meta-analysis
10.12968/jowc.2022.0213 · ExternalCitation · doi-reference
Intralesional epidermal growth factor therapy in recalcitrant diabetic foot ulcers
10.12968/jowc.2023.32.sup4.s14 · ExternalCitation · doi-reference
Autologous adipose-derived tissue stromal vascular fraction and intralesional epidermal growth factor combined application in patients with diabetic foot
10.12968/jowc.2024.0107 · ExternalCitation · doi-reference
A comparison of necrotising fasciitis in diabetics and non-diabetics: A review of 127 patients
10.1302/0301-620x.98b11.37526 · ExternalCitation · doi-reference
Necrotizing fasciitis: Clinical presentation, microbiology, and determinants of mortality
10.2106/00004623-200308000-00005 · ExternalCitation · doi-reference
Etiology, epidemiology, and disparities in the burden of diabetic foot ulcers
10.2337/dci22-0043 · ExternalCitation · doi-reference
10.3389/fendo.2023.1323315
10.3389/fendo.2023.1323315 · ExternalCitation · doi-reference
10.3389/fsurg.2021.655902
10.3389/fsurg.2021.655902 · ExternalCitation · doi-reference
10.3390/biomedicines10123145
10.3390/biomedicines10123145 · ExternalCitation · doi-reference
Heberprot-P’s effect on gene expression in healing diabetic foot ulcers
10.37757/mr2018.v20.n3.4 · ExternalCitation · doi-reference
Epidermal growth factor in healing diabetic foot ulcers: From gene expression to tissue healing and systemic biomarker circulation
10.37757/mr2020.v22.n3.7 · ExternalCitation · doi-reference
Primary necrotizing fasciitis of the breast: Case series with 5 patients
10.3855/jidc.14914 · ExternalCitation · doi-reference
The effect of comorbid factors and amputation level on mortality in geriatric patients with diabetic foot
10.52312/jdrs.2023.818 · ExternalCitation · doi-reference
